| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |